erlotinib hydrochloride has been researched along with cyclosporine in 2 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 30,547 | 3,802 | 6,558 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catania, C; Curigliano, G; de Braud, F; De Carlis, L; De Pas, T; Locatelli, M; Lorizzo, K; Pelosi, G; Spitaleri, G; Toffalorio, F | 1 |
Cikes, M; Hecimovic, A; Jakopovic, M; Jankovic Makek, M; Samarzija, M; Vukic Dugac, A | 1 |
2 other study(ies) available for erlotinib hydrochloride and cyclosporine
Article | Year |
---|---|
Erlotinib combined with cyclosporine in a liver-transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclosporine; ErbB Receptors; Erlotinib Hydrochloride; Humans; Liver Transplantation; Lung Neoplasms; Male; Middle Aged; Mutation; Quinazolines | 2009 |
Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patient.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Heart Transplantation; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Mutation | 2019 |